From 40 calls to 261 in one morning: rollout issues continue GPs have stepped up to help protect patients, but issues with the national booking system left NSW practice staff scrambling to reschedule fast-tracked appointments.
Confusion over PM’s call to shorten interval between AstraZeneca doses Scott Morrison suggested people in Greater Sydney receive their second AstraZeneca dose after eight weeks instead of 12, despite data showing lower efficacy rates.
Herd immunity likely to be ‘made harder’ by variants New modelling has underlined the increasing scale of Australia’s vaccination challenge as it aims to open up to the world.
Supply issues remain despite positive start to general practice Pfizer rollout GPs say there is need for greater supply certainty and timely delivery ahead of another 500 practices joining the rollout next week.
GPs given ‘uncertain’ estimates for risk–benefit vaccine consultations The fact sheet GPs have been asked to use when discussing AstraZeneca vaccines with patients aged under 60 relies on limited information that fails to consider extensive data from abroad.
National Cabinet reveals plan to eventually treat COVID ‘just like the flu’ The Prime Minister has mapped out Australia’s proposed long-term pandemic strategy, but the details of many trigger points are yet to be confirmed.
AstraZeneca debate a ‘failure of pandemic management’ RACGP President Dr Karen Price has stressed the decision around COVID vaccination should be shared by patients and GPs without outside interference.
Practices scramble to adapt to vaccine rollout changes General practices have had to adapt at speed once again following another significant shift in COVID-19 vaccination guidance.
New national vaccine advertising campaign needed: RACGP The college has called on the Federal Government to urgently fill an information vacuum that is being taken advantage of by anti-vaxxers.
National Cabinet announces no-fault indemnity scheme for GPs to administer AstraZeneca The move opens the door for under-60s to receive the vaccine as the country looks to speed up the rollout amid a potential national outbreak.